Abstract
Intraocular metastases are the most common malignancy of the eye, and the primary cause is breast cancer. This is a retrospective analysis, which reports the clinical experience of eye metastases in 16 patients during the period of January, 1991, to December, 2002, who attended a tertiary referral center in Mexico City. Mean age at diagnosis was 40 yr (range 24–58). Most of patients were initially in clinical stage IIB-IV. Median time from breast cancer diagnosis to development of ocular metastases was 22.5 mo and from metastatic disease to ocular metastases was 10 mo. Ocular symptoms were decrease of visual acuity, ocular pain, nonspecific symptoms, proptosis, and palpebral edema. Three patients had bilateral ocular metastases. Fourteen patients were treated with radiation, and clinical response was documented in 4/15 eyes; ocular pain responded in three patients with this symptom. No ocular enucleations were performed. One patient developed glaucoma. No other major toxicities were documented. Median survival time was 26 mo and 25% of our patients were alive at a maximum follow-up of 90 mo. This entity requires early recognition in order to preserve the visual function and quality of life of patients with breast cancer, since their prognosis has improved in recent years.
Similar content being viewed by others
References
Small W. Management of the ocular metastasis. Cancer Control 1998; 5:326–332.
Bloch RS, Gartner S. The incidence of ocular metastatic carcinoma. Arch Ophtalmol 1971; 85:673–675.
Eliassi-Rad B, Albert DM, Green WR. Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol 1996; 80:125–128.
Reeves D, Levine MR, Lash R. Nonpalpable breast carcinoma presenting as orbital infiltration: case presentation and literature review. Ophthal Plast Reconstr Surg 2002; 18:84–88.
Wiegel T, Bornfeld N, Kreusel KM, Guttenberger R, Hinkelbein W. Radiotherapy for choroidal metastases: interim analysis of a prospective study of the ARO(ARO 95-08). Front Radiat Ther Oncol 1997; 30:154–159.
Wiegel T, et al. Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme. Br J Ophthalmol 1992; 82:1159–1161.
Edwards MJ, Gamel JW, Feuer EJ. Improvement in the prognosis of breast cancer from 1965 to 1984. J Clin Oncol 1998; 16:1030–1035.
Shields J, et al. Cancer metastatic to the orbit. Adv Ophthalmic Plast Reconstr Surg 2001; 17:346–354.
Brady L, Shields J, Ausburger J, Day J. Malignant intraocular Tumors. Cancer 1982; 49:578–585.
Ratanatharathorn V, Powers WE, Grijj J. Eye metastases from carcinoma of the breast: diagnosis, radiation treatment and results. Cancer Treat Rev 1991; 18:261–276.
Rahal F, Abramson D, David H, Servodidio C, Abramson H. Automated perimetry in patients with coroidal metastases. Br J Ophthalmol 1996; 80:309–313.
McCaffery S, et al. Three-dimensional high-resolution magnetic resonance imaging of ocular and orbital malignancies. Arch Ophthalmol 2002; 120:747–754.
Parsons JT, Bova F, Fitzgerald C, Mendenhall W, Million R. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys 1994; 30:775–780.
Parsons JT, Bova F, Fitzgerald C, Mendenhall W, Million R. Radiation retinopathy after external beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30:765–774.
Shields C, et al. Plaque radiotherapy for the management of uveal metastasis. Arch Ophthalmol 1997; 115:203–209.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mejía-Novelo, A., Alvarado-Miranda, A., Morales-Vázquez, F. et al. Ocular metastases from breast carcinoma. Med Oncol 21, 217–221 (2004). https://doi.org/10.1385/MO:21:3:217
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:21:3:217